SKIL Promotes Pancreatic Cancer Metastasis by Inhibiting TSPYL2 to Activate the TGF-β PathwayOA
SKIL Promotes Pancreatic Cancer Metastasis by Inhibiting TSPYL2 to Activate the TGF-β Pathway
Chenxi Wang;Weiwei Song;Yixuan Zhang;Hongming Deng;Zixiang Zhou;Jing Zhu;Xiaobing Wang
State Key Laboratory of Molecular Oncology,National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing,ChinaState Key Laboratory of Molecular Oncology,National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing,ChinaNMPA Key Laboratory for Monitoring and Evaluation of Cosmetics,Shanghai Innovation R&D,Testing and Evaluation Technical Service Platform of Cosmetics(22DZ2292100),Shanghai,ChinaState Key Laboratory of Molecular Oncology,National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing,ChinaDepartment of Molecular Biology,Princeton University,Princeton,New Jersey,USACollege of Nursing and Health Innovation,The University of Texas Arlington,Arlington,Texas,USAState Key Laboratory of Molecular Oncology,National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing,China
epithelial-mesenchymal transitionpancreatic adenocarcinomaSKILTGF-β pathwayTSPYL2
epithelial-mesenchymal transitionpancreatic adenocarcinomaSKILTGF-β pathwayTSPYL2
《肿瘤学创新（英文）》 2025 (3)
101-113,13
This project was supported by the National Natural Science Foundation Fund(Grant Nos.82372696,82172988),the Chinese Academy of Medical Sciences(CAMS)Innovation Fund for Medical Sciences(CIFMS)(Grant No.2021-I2M-1-014),and the Cooperation Fund of CHCAMS and SZCH(Grant No.CFA202201006).
评论